President Donald Trump announced a deal with AstraZeneca to provide lower-cost prescription drugs to American consumers, promising significant discounts on medications. This follows a similar agreement with Pfizer, both companies agreeing to invest in U.S. manufacturing and avoid tariffs, with Trump citing his tariff threats as key to securing these deals.
Loading PerspectiveSplit analysis...
